Business Standard

Monday, December 23, 2024 | 04:59 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Lincoln Pharma Q3 net up 23% to Rs 13 cr on strong domestic, global biz

Firm to expand product basket, prepares for entry into European market

markets, stock market, sensex, correction, nifty, shares, growth, profit, economy, gain
Premium

The drug maker's consolidated total revenue also grew by 13.70 per cent to Rs 115.47 crore in Q3 of FY 2020-21, from Rs 101.55 crore in Q3 of FY 2019-20

Vinay Umarji Ahmedabad
On the back of strong domestic and international business, Lincoln Pharmaceuticals Limited posted a 23.44 per cent rise in its consolidated net profit for the third quarter ended December 31, 2020 at Rs 13.48 crore, from Rs 10.92 crore in the same quarter last year.

The drug maker's consolidated total revenue also grew by 13.70 per cent to Rs 115.47 crore in Q3 of FY 2020-21, from Rs 101.55 crore in Q3 of FY 2019-20. 

According to Lincoln Pharma's managing director Mahendra Patel, the growth in revenue and profit came on the back of strong domestic and international business. The company posted

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in